Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AVANT Immunotherapeutics Inc. (Nasdaq: AVAN) -- Ignore unavailable to you. Want to Upgrade?

To: Scott Ozer who wrote (225)	5/18/1998 2:23:00 PM
From: sol dude	Read Replies (1) \| Respond to of 513

Just venting frustration. This the second time i bought this stock at 3.125 and had it go uo for a few days and watched it waste away. Last 96 I sold at 2 for a loss. This time I thought the novartis deal would put them over. Then the 2000000 shares at 2ish now this merger and here we go again on our way to 2. Everyday tons of news on bios yet most of the stocks go down, some lower than where they started the year severely undervalued. They all just keep diluting there shares. eventually they will go up, but not until they get actual approvals. Unfortunately because of dilution our profits will be limited. soldude